Italia markets closed

BMY Aug 2025 35.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,77000,0000 (0,00%)
Alla chiusura: 10:54AM EDT
Schermo intero
Chiusura precedente1,7700
Aperto1,7900
Denaro1,4200
Lettera1,6100
Prezzo d'esercizio35,00
Scadenza2025-08-15
Min-Max giorno1,7600 - 1,7900
Contratto - Min-MaxN/D
Volume42
Open Interest84
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri